These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6147144)

  • 1. Dynorphin A: inhibitory effect on other opiate ligand bindings in the mouse brain.
    Garzón J; Sánchez-Blázquez P; Gerhart J; Loh HH; Lee NM
    Biochem Pharmacol; 1984 Aug; 33(16):2609-14. PubMed ID: 6147144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynorphin is a specific endogenous ligand of the kappa opioid receptor.
    Chavkin C; James IF; Goldstein A
    Science; 1982 Jan; 215(4531):413-5. PubMed ID: 6120570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynorphin1-13: interaction with other opiate ligand bindings in vitro.
    Garzón J; Sánchez-Blázquez P; Gerhart J; Loh HH; Lee NM
    Brain Res; 1984 Jun; 302(2):392-6. PubMed ID: 6329465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that dynorphin-(1-13) acts as an agonist on opioid kappa-receptors.
    Oka T; Negishi K; Suda M; Sawa A; Fujino M; Wakimasu M
    Eur J Pharmacol; 1982 Jan; 77(2-3):137-41. PubMed ID: 6277659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynorphin(1-13), a long-lasting inhibitor of opiate receptor binding in vitro.
    Garzón J; Jen MF; Sánchez-Blázquez P; Lee NM
    Life Sci; 1982 Oct 18-25; 31(16-17):1789-92. PubMed ID: 6130441
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential effect of humoral endorphin on the binding of opiate agonists and antagonists.
    Sarne Y; Itzhak Y; Keren O
    Eur J Pharmacol; 1982 Jul; 81(2):227-35. PubMed ID: 6288405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynorphin inhibition of the neurotensin contractile activity on the myenteric plexus.
    Huidobro-Toro JP; Zhu YX; Lee NM; Loh HH; Way EL
    J Pharmacol Exp Ther; 1984 Feb; 228(2):293-303. PubMed ID: 6141281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynorphin-(1-13): the effect of in vivo treatment on opiate bindings in vitro.
    Jen MF; Garzon J; Loh HH; Lee NM
    Eur J Pharmacol; 1983 Jul; 91(1):95-9. PubMed ID: 6311575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kappa opioid properties of dynorphin and its peptide fragments on the guinea-pig Ileum.
    Yoshimura K; Huidobro-Toro JP; Lee NM; Löh HH; Way EL
    J Pharmacol Exp Ther; 1982 Jul; 222(1):71-9. PubMed ID: 6123594
    [No Abstract]   [Full Text] [Related]  

  • 10. Dynorphin-(1-13) restores the potency of morphine on the tolerant guinea pig ileum.
    Rezvani A; Way EL
    Eur J Pharmacol; 1984 Jul; 102(3-4):475-9. PubMed ID: 6149134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental kappa binding site : interaction with dynorphin and its possible implication in hCG secretion.
    Valette A; Tafani M; Porthe G; Pontonnier G; Cros J
    Life Sci; 1983; 33 Suppl 1():523-6. PubMed ID: 6141498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central cardiovascular effects of kappa agonists dynorphin-(1-13) and ethylketocyclazocine in the anaesthetized rat.
    Laurent S; Schmitt H
    Eur J Pharmacol; 1983 Dec; 96(1-2):165-9. PubMed ID: 6319158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opiate and opioid peptide binding in rat goldfish: further evidence for opiate receptor heterogeneity.
    Nishimura S; Pasternak GW
    Brain Res; 1982 Sep; 248(1):192-5. PubMed ID: 6289993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potency of three opiate antagonists to reverse the inhibitory activity of dynorphin, enkephalins and opioid-like alkaloids on the guinea pig ileum.
    Yoshimura K; Huidobro-Toro JP; Way EL
    Eur J Pharmacol; 1982 Oct; 84(1-2):17-24. PubMed ID: 6128236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposite central cardiovascular effects of various morphine-like drugs and opiate peptides in the rat.
    Laurent S; Schmitt H
    Eur Heart J; 1983 Nov; 4 Suppl G():61-5. PubMed ID: 6363080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is dynorphin a k ligand?
    Lee NM
    Proc West Pharmacol Soc; 1983; 26():309-11. PubMed ID: 6136981
    [No Abstract]   [Full Text] [Related]  

  • 17. Activation of K-opiate sites by dynorphin in the myenteric plexus.
    Yoshimura K; Huidobro-Toro JP; Lee NM; Loh HH; Way EL
    Adv Biochem Psychopharmacol; 1982; 33():91-8. PubMed ID: 6127009
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiple opiate receptors: [3H]ethylketocyclazocine receptor binding and ketocyclazocine analgesia.
    Pasternak GW
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3691-4. PubMed ID: 6251477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological effects of dynorphin peptides on hippocampal pyramidal cells in rat.
    Moises HC; Walker JM
    Eur J Pharmacol; 1985 Jan; 108(1):85-98. PubMed ID: 2858395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrinsic activity and effects of guanyl-5'-yl imidodiphosphate, Gpp(NH)p and sodium ion on the affinity of dynorphin 1-13, nalorphine and nalorphine-7,8-oxide to kappa-opioid receptor.
    Takayanagi I; Okumura K; Konno F; Koike K; Cho N; Hirobe M
    Gen Pharmacol; 1985; 16(6):617-9. PubMed ID: 2867951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.